📢 🌟 Exciting News! Stratpharma is thrilled to announce its participation in the 16th 5CC - World Congress in Lisbon! 🌟 📆 When? June 13-16, 2024 📍 Where? Centro de Congressos de Lisboa, Lisbon This prestigious event will be diving deep into the latest advancements in medical dermatology. Join us at Booth 2223 to discover our latest innovations in dermatology and discover how we’re committed to improving patients’ lives and well-being. We will showcase our wide range of products tailored for #Dermatology, #PlasticSurgery, #WoundCare, Scar Management,, and Oncology Supportive Care, including: - Strataderm® - Our silicone gel formulation for the prevention and treatment of abnormal scars, both old and new. - Stratamed® - Our advanced film-forming wound dressing for use immediately following medical and aesthetic procedures. - Stratacel® - Our wound dressing specifically designed for the repair of damaged or compromised skin following resurfacing procedures. - Stratamark® - A breakthrough in the prevention and treatment of Stretch Marks. Don't miss this opportunity to connect with us and learn how our products are making a difference in patient care. See you in #Lisbon! ☺️ #skincare #HealthcareInnovation #medicaldevices #Stratpharma #events
Stratpharma’s Post
More Relevant Posts
-
The December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and clinical insights shaping the landscape of dermatological care. From innovative treatment modalities to emerging trends in skincare, JDD contributors explore the intersection of science and practice to provide valuable perspectives for dermatologists, healthcare professionals, and researchers alike. Join us in navigating the ever-evolving world of dermatology as we showcase the forefront of knowledge in the December 2023 edition of JDD. #Dermatology #Dermatologist #SkinExperts #CosmeticDermatology #MedicalDermatology #SkinTreatment #DermResidents #DermatologyTraining #ResidentLife #DermatologyResidents #dermatologyjournals #DermatologyCases #DermatologyResearch #SkinMedicine #ResidentEducation #DermatologyFellowship #BoardPrep
To view or add a comment, sign in
-
Psoriasis impacts over 125 million people worldwide. Medpace's dedicated dermatology experts persist in their mission to propel drug development, providing vital support to those facing the challenges of Psoriasis. Our in-house board-certified dermatologist, Kara Smolinski MD, PhD, has the expertise to provide hands-on leadership throughout clinical trials across many indications. Learn more about Medpace's #dermatology capabilities today: https://lnkd.in/gDn_Jxa5. #PsoriasisActionMonth
To view or add a comment, sign in
-
🌟 Specialty Select: Thinking of Specializing in Dermatology? – Featuring Dr. Kok Wai Leong 🌟 (Part 2 of 4 in the Health Insider series on POMConnect) Healthcare professionals, have you ever considered specializing in dermatology? Dr. Wai Leong Kok shares his inspiring journey from childhood struggles with atopic eczema to becoming a senior consultant dermatologist. His personal experiences provide a unique perspective on the impact of skin disorders and the empathy needed to connect with patients. 💡 Highlights: - Dermatology as visual-centric clinical medicine, akin to solving complex puzzles - Bridging the gap between patient expectations and clinical reality - Keys to success: quality patient care, humility, and passion - The future of dermatology: AI, personalized and precision medicine - Dispelling misconceptions about dermatology Join Dr. Wai Leong Kok in this second article of his Health Insider series as he explores the rewarding journey and future prospects of dermatology. 👉 Read more on POMConnect: https://shorturl.at/zJaUb #HealthcareProfessionals #Dermatology #MedicalPractice #POMConnect #HealthInsider #SpecialtySelect #PatientCare #FutureOfMedicine
To view or add a comment, sign in
-
-
Many people don't know that Science 37 was actually founded by two dermatologists almost 10 years ago. 👨⚕️ 👨⚕️ That's only one of the reasons why our model works great for your dermatology studies. Clearly, it can be challenging to identify and support patients who have not previously participated in a clinical trial, or used medications that might be exclusionary for a particular study. Because of these particular dynamics, decentralized clinical trials present a unique solution as they enable expansive reach and access. Click the link in the comments and find out how our model accelerated enrollment for a dermatology trial! #dermatology #DCT #science37
To view or add a comment, sign in
-
-
Director, Inflammatory Skin Disease Service at Hadassah Medical Center and Associate Professor at The Hebrew University of Jerusalem
🌟 Exciting Announcement! 🌟 Join us for a scientific virtual meeting on June 3rd, 2024, from 20:00 to 21:20 (Israel time). I will chair this event, which will cover two pivotal topics in dermatology: 🩺 Topic 1: Deucravacitinib for Psoriasis Dr. Felix Pavlotsky will explore the unique features, efficacy, and safety of Deucravacitinib, a newly approved oral treatment for psoriasis. This session promises to provide valuable insights into practical aspects of its use in patients. 🩺 Topic 2: Treating Actinic Keratosis in Summer Managing actinic keratosis during the hot summer months poses unique challenges due to increased sun sensitivity. Prof. Assi Levi will discuss strategies to effectively treat these lesions even during Israel's long, hot summers. 🔗 Register now: https://lnkd.in/d29Sm9Fq Don't miss this opportunity to enhance your knowledge and connect with peers in the dermatology community! #Dermatology #VirtualMeeting #Psoriasis #ActinicKeratosis #MedicalEducation #Healthcare
To view or add a comment, sign in
-
-
✨Topical mTOR Inhibitors: Innovative Dermatology Treatment for Challenging Skin Conditions Georgetown University's breakthrough in topical mTOR inhibitors can provide an innovative approach to treating cutaneous vascular and proliferative conditions; this innovation brings hope to patients with rare and unmet dermatologic challenges. From acne to complex skin disorders, discover the transformative potential of minimally invasive, topically applied mTOR inhibitors for improved patient outcomes. It addresses many dermatological conditions, providing a versatile solution for different patient needs and offers a unique and effective treatment for various skin conditions without current therapeutic options. Cynthia DeKlotz Join the journey of innovation and explore the science behind this game-changing technology. 🔍🚀 [https://lnkd.in/gZjw_2UE] #DermatologyInnovation #SkinTherapies #GeorgetownOTC #GeorgetownUniversity #Innovation #TechTransfer
To view or add a comment, sign in
-
-
📢 September 2023's British Journal of Dermatology Summaries are now available to view. 📢 The summaries aim to make #dermatology research findings more accessible to those without formal medical training. Below is the link to the summary that has a particular focus on #psoriasis: Comparison of treatment for psoriasis with methotrexate and adalimumab https://ow.ly/o6ks50PPyhG ⭐️ If you would you like to join the BJD's Plain Language Summaries mailing list and receive these updates straight to your inbox, you can subscribe here: http://ow.ly/USof50JFAFL
To view or add a comment, sign in
-
-
📢Happening NEXT WEEK📢 "Optimizing Endpoint Assessments for Dermatology Studies"! Join WCG experts Ericka Atkinson, Jan Sedway, and Bryan Wayne, for an in-depth look at dermatology trials and how standardized rater qualification and training can address challenges and maintain endpoint data integrity. You don't want to miss these insights. Register now at https://lnkd.in/eqMccxrx to join us next Thursday, September 14th! #DermatologyStudies #ClinicalTrials #RaterQualfication #EndpointAssessments
To view or add a comment, sign in
-
We've helped over 4,000 dermatology patients during the past 12 months. Annually over a million new patients are referred to specialist dermatology departments, with around 50% of these relating to diagnosing and managing skin lesions and skin cancer. Our dedicated and fully accredited teams of healthcare professionals provide an additional workforce to NHS Trusts and Health Boards to help clear waiting list backlogs by seeing more patients over a shorter timeframe. We're immensely proud to be an NHS Partner and support so many dermatology patients. With SHS Partners, every patient is a person, not a number on a waiting list. #NHSPartner #Insourcing #patientwaitinglist #nhswaitinglist #dermatology #skincancer
To view or add a comment, sign in
-
Exciting! See you in Lisbon 🤝